Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grand Cathay Securities Corporation was a prominent Taiwanese investment bank and brokerage firm. Established in 1988, the company offered comprehensive financial services, including securities trading, underwriting, and corporate finance advisory. It operated as a key subsidiary of China Development Financial Holding Corporation (CDF). In 2013, Grand Cathay Securities was merged into KGI Securities, another CDF subsidiary, to consolidate the group's brokerage operations. The firm was particularly noted for its role in supporting the growth of Taiwan's high-tech and biotechnology sectors through capital raising and advisory services. Although no longer an independent entity, its legacy remains significant in the history of Taiwan's capital market development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grand Cathay Securities.